ilmscore | Prediction Details
"Its furthest indication though is still in Phase One trials which means it's going to be years before any approvals"
By Let's Talk Money! with Joseph Hogue, CFA | June 14, 2024 | Pending
From video
7 AI Stocks to Buy Revolutionizing Healthcare 00:15:03 - 00:15:06
Interpreted Prediction
Schrodinger Inc.'s (SDRG) furthest drug indication is still in Phase One trials, meaning it will be years before any approvals are granted.

Prediction Details

Ticker
SDRG

Comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.